Siegmund Karasch
Director/Board Member en DEUTSCHE BIOTECH INNOVATIV AG .
Perfil
Siegmund Karasch founded AdrenoMed AG.
Mr. Karasch is on the board of Deutsche Biotech Innovativ AG.
In the past he was Chief Executive & Operating Officer of InVivo BioTech Services GmbH and Member-Supervisory Board at AdrenoMed AG.
Mr. Karasch received an undergraduate degree from Hochschule für Technik und Wirtschaft Berlin.
Cargos activos de Siegmund Karasch
Empresas | Cargo | Inicio |
---|---|---|
DEUTSCHE BIOTECH INNOVATIV AG | Director/Board Member | 05/07/2018 |
Antiguos cargos conocidos de Siegmund Karasch.
Empresas | Cargo | Fin |
---|---|---|
AdrenoMed AG
AdrenoMed AG Pharmaceuticals: MajorHealth Technology AdrenoMed AG develops a drug to decrease mortality in severe sepsis. The company was founded by Bernd Wegener, Gerald Heinz Möller and Andreas Bergmann in 2009 and is headquartered in Berlin, Germany. | Founder | 01/01/2014 |
InVivo BioTech Services GmbH
InVivo BioTech Services GmbH Medical SpecialtiesHealth Technology InVivo BioTech Services GmbH engages in contract manufacturing organization dedicated to the development and production of monoclonal antibodies and expression of recombinant proteins. The company was founded by Andreas Bergmann in 1998 and is headquartered in Hennigsdorf, Germany. | Chief Executive Officer | - |
Formación de Siegmund Karasch.
Hochschule für Technik und Wirtschaft Berlin | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
DEUTSCHE BIOTECH INNOVATIV AG | Finance |
Empresas privadas | 2 |
---|---|
InVivo BioTech Services GmbH
InVivo BioTech Services GmbH Medical SpecialtiesHealth Technology InVivo BioTech Services GmbH engages in contract manufacturing organization dedicated to the development and production of monoclonal antibodies and expression of recombinant proteins. The company was founded by Andreas Bergmann in 1998 and is headquartered in Hennigsdorf, Germany. | Health Technology |
AdrenoMed AG
AdrenoMed AG Pharmaceuticals: MajorHealth Technology AdrenoMed AG develops a drug to decrease mortality in severe sepsis. The company was founded by Bernd Wegener, Gerald Heinz Möller and Andreas Bergmann in 2009 and is headquartered in Berlin, Germany. | Health Technology |